NA
GWPH

NewEdge Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

NewEdge Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,619
Closed -$302K – 1135
2020
Q4 		$302K Buy
+2,619
New +$293K 0.01% 757
2017
Q3 		– Sell
-100
Closed -$10K – 1243
2017
Q2 		$10K Buy
+100
New +$10.8K ﹤0.01% 959

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewEdge Advisors's GWPH Position: Q1 2021 in Review

NewEdge Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,619 shares — an estimated $302K sold.

NewEdge Advisors first reported a position in GWPH in Q2 2017 and held it in 2 quarters. The position peaked at $302K in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • NewEdge Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • NewEdge Advisors sold 2,619 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $302K.
  • NewEdge Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2017 and held it in 2 quarters.
  • NewEdge Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $302K in Q4 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on NewEdge Advisors's 13F filing for Q1 2021, filed 26 Apr 2021.